|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.20 EUR | -0.92% |
|
-0.50% | -36.36% |
| Jul. 14 | Biomérieux Showcases Latest Diagnostic Solutions and Innovations At ADLM 2026 | CI |
| Jul. 10 | Sadif Investment Analytics Upgrades bioMérieux to Hold Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 9.53B | |||||
| 21B | - | ||||
| 6.86B | |||||
| 5.3B | - | ||||
| 5.12B | |||||
| 4.82B |
- Stock Market
- Stocks
- BIM Stock
- Charts bioMérieux
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
